Skip to content

Clinical trials

Completed Phase 1/2 Leukemia, Mast-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Mast-Cell Phase: Phase 1/2 Status: Completed Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20091

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center1
Fred Hutchinson Cancer Center1
UNC Lineberger Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma3
Hodgkin Disease3
Immunoblastic Lymphadenopathy3
Intraocular Lymphoma3
Leukemia, Hairy Cell3
Leukemia, Large Granular Lymphocytic3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Mast-Cell3
Leukemia, Myeloid, Acute3
Leukemia, Myelomonocytic, Chronic3

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.